120 related articles for article (PubMed ID: 36757738)
1. Structural and Molecular Fusion MRI Nanoprobe for Differential Diagnosis of Malignant Tumors and Follow-Up Chemodynamic Therapy.
Yang W; Deng C; Shi X; Xu Y; Dai C; Wang H; Bian K; Cui T; Zhang B
ACS Nano; 2023 Feb; 17(4):4009-4022. PubMed ID: 36757738
[TBL] [Abstract][Full Text] [Related]
2. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
3. T
Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
[TBL] [Abstract][Full Text] [Related]
4. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Specific Endogenous Fe
Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.
Sobhani T; Shahbazi-Gahrouei D; Rostami M; Zahraei M; Farzadniya A
J Med Signals Sens; 2019; 9(4):245-251. PubMed ID: 31737553
[TBL] [Abstract][Full Text] [Related]
7. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy.
Wang J; Kong W; Jin H; Li C; Luo Q; Luo Y; Yuan C; Lu J; Zhang L; Liu X
Colloids Surf B Biointerfaces; 2022 Oct; 218():112750. PubMed ID: 35961116
[TBL] [Abstract][Full Text] [Related]
9. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
10. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.
Zhang B; Zhu B; Li M; Yuan L; Yuan L; Zhang X; Yu H; Li C; Lu F; Zhou Z; Zhuang X
Acta Radiol; 2012 Jul; 53(6):607-14. PubMed ID: 22761342
[TBL] [Abstract][Full Text] [Related]
11. Effective Combination of Isoniazid and Core-Shell Magnetic Nanoradiotherapy Against Gastrointestinal Tumor Cell Types.
Chen H; Zhu D; Guo L; Li G
Int J Nanomedicine; 2022; 17():1005-1014. PubMed ID: 35299864
[TBL] [Abstract][Full Text] [Related]
12. Simultaneously activating highly selective ratiometric MRI and synergistic therapy in response to intratumoral oxidability and acidity.
Liu Y; Jia Q; Guo Q; Wei W; Zhou J
Biomaterials; 2018 Oct; 180():104-116. PubMed ID: 30032045
[TBL] [Abstract][Full Text] [Related]
13. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall Fe@Fe
Liu D; Li J; Wang C; An L; Lin J; Tian Q; Yang S
Nanomedicine; 2021 Feb; 32():102335. PubMed ID: 33220508
[TBL] [Abstract][Full Text] [Related]
15. Microemulsion-Confined Biomineralization of PEGylated Ultrasmall Fe
Liu W; Yin S; Hu Y; Deng T; Li J
Anal Chem; 2021 Oct; 93(42):14223-14230. PubMed ID: 34647451
[TBL] [Abstract][Full Text] [Related]
16. PDGFB targeting biodegradable FePt alloy assembly for MRI guided starvation-enhancing chemodynamic therapy of cancer.
Zhang C; Leng Z; Wang Y; Ran L; Qin X; Xin H; Xu X; Zhang G; Xu Z
J Nanobiotechnology; 2022 Jun; 20(1):264. PubMed ID: 35672821
[TBL] [Abstract][Full Text] [Related]
17. Eradication of solid tumors by chemodynamic theranostics with H
Wang N; Zeng Q; Zhang R; Xing D; Zhang T
Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.
Li X; Hu JL; Zhu LM; Sun XH; Sheng HQ; Zhai N; Hu XB; Sun CR; Zhao B
Tumour Biol; 2015 Jul; 36(7):5515-22. PubMed ID: 25724182
[TBL] [Abstract][Full Text] [Related]
19. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
[TBL] [Abstract][Full Text] [Related]
20. Hetero-Core-Shell BiNS-Fe@Fe as a Potential Theranostic Nanoplatform for Multimodal Imaging-Guided Simultaneous Photothermal-Photodynamic and Chemodynamic Treatment.
Ma S; Xie J; Wang L; Zhou Z; Luo X; Yan J; Ran G
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10728-10740. PubMed ID: 33645960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
